Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium

Laura Ceriotti,1 Silvia Balzaretti,1 Salvatore Barone,2 Marisa Meloni1 1VitroScreen, Milan, Italy; 2NTC S.r.l., Milan, ItalyCorrespondence: Laura CeriottiVitroScreen, Via Mosè Bianchi 103, Milan 20149, ItalyTel +39 02 89077608Email laura.ceriotti@vitroscreen.comObjective: To assess the ey...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ceriotti L, Balzaretti S, Barone S, Meloni M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	bak biocompatibility delayed toxicity hce microglycine Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/8a11e48ce334459db7674892dcbf9599
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8a11e48ce334459db7674892dcbf9599
record_format	dspace
spelling	oai:doaj.org-article:8a11e48ce334459db7674892dcbf95992021-12-02T06:31:51ZEye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium1177-5483https://doaj.org/article/8a11e48ce334459db7674892dcbf95992020-01-01T00:00:00Zhttps://www.dovepress.com/eye-irritation-potential-of-microglycine-and-microglycine-containing-o-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Laura Ceriotti,1 Silvia Balzaretti,1 Salvatore Barone,2 Marisa Meloni1 1VitroScreen, Milan, Italy; 2NTC S.r.l., Milan, ItalyCorrespondence: Laura CeriottiVitroScreen, Via Mosè Bianchi 103, Milan 20149, ItalyTel +39 02 89077608Email laura.ceriotti@vitroscreen.comObjective: To assess the eye tolerability of a buffered ophthalmic solution containing microglycine (sodium hydroxymethylglycinate, mwaterTM) in an in vitro model.Materials and Methods: A multiple endpoint analysis (MEA) approach was applied to the reconstructed human corneal epithelium (HCE) model. Sodium hydroxymethylglycinate solution (0.04%) and two ophthalmic ointments containing microglycine (Protectorial, containing 0.02% of sodium hydroxymethylglycinate, and Edenight, containing 0.04% of sodium hydroxymethylglycinate) were investigated. The buffered solution and the ointments were tested on HCE after acute (one application in 24 hrs, followed or not by 16 hrs of recovery) or repeated (one application per day for three consecutive days) exposures; benzalkonium chloride (BAK) 0.01% and saline isotonic solution were used as positive and negative controls, respectively. Cellular viability, trans-epithelial electrical resistance (TEER), lactate dehydrogenase (LDH) release and histo-morphology were evaluated.Results: BAK 0.01% toxicity in HCE was confirmed for the 24+16 hrs acute and repeated exposure protocols, while, after 24–hours acute treatment, only modifications of the superficial cell layer were visible compared with the negative control. Sodium hydroxymethylglycinate had a very good tolerability profile and a neutral impact on the corneal surface after acute or repeated exposure. The Protectorial and Edenight ointments preserved cell viability in the different exposure protocols, suggesting a good local tolerability profile. Modifications of the superficial layers were observed on histo-morphological analysis and confirmed by increased release of LDH after 24+16 hrs acute exposure (+65% and +76% for Protectorial and Edenight, respectively) and TEER values after 24+16 hrs and 72 hrs exposure protocols. These results were dependent on the ointments’ accumulation on the corneal epithelium due to their physical form (semi-solid) and lipophilic properties.Conclusion: Sodium hydroxymethylglycinate, alone or as part of eye ointments, was found to be non-toxic after acute or repeated exposure in the reconstructed HCE model.Keywords: BAK, biocompatibility, delayed toxicity, HCE, microglycineCeriotti LBalzaretti SBarone SMeloni MDove Medical Pressarticlebakbiocompatibilitydelayed toxicityhcemicroglycineOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 257-267 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	bak biocompatibility delayed toxicity hce microglycine Ophthalmology RE1-994
spellingShingle	bak biocompatibility delayed toxicity hce microglycine Ophthalmology RE1-994 Ceriotti L Balzaretti S Barone S Meloni M Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
description	Laura Ceriotti,1 Silvia Balzaretti,1 Salvatore Barone,2 Marisa Meloni1 1VitroScreen, Milan, Italy; 2NTC S.r.l., Milan, ItalyCorrespondence: Laura CeriottiVitroScreen, Via Mosè Bianchi 103, Milan 20149, ItalyTel +39 02 89077608Email laura.ceriotti@vitroscreen.comObjective: To assess the eye tolerability of a buffered ophthalmic solution containing microglycine (sodium hydroxymethylglycinate, mwaterTM) in an in vitro model.Materials and Methods: A multiple endpoint analysis (MEA) approach was applied to the reconstructed human corneal epithelium (HCE) model. Sodium hydroxymethylglycinate solution (0.04%) and two ophthalmic ointments containing microglycine (Protectorial, containing 0.02% of sodium hydroxymethylglycinate, and Edenight, containing 0.04% of sodium hydroxymethylglycinate) were investigated. The buffered solution and the ointments were tested on HCE after acute (one application in 24 hrs, followed or not by 16 hrs of recovery) or repeated (one application per day for three consecutive days) exposures; benzalkonium chloride (BAK) 0.01% and saline isotonic solution were used as positive and negative controls, respectively. Cellular viability, trans-epithelial electrical resistance (TEER), lactate dehydrogenase (LDH) release and histo-morphology were evaluated.Results: BAK 0.01% toxicity in HCE was confirmed for the 24+16 hrs acute and repeated exposure protocols, while, after 24–hours acute treatment, only modifications of the superficial cell layer were visible compared with the negative control. Sodium hydroxymethylglycinate had a very good tolerability profile and a neutral impact on the corneal surface after acute or repeated exposure. The Protectorial and Edenight ointments preserved cell viability in the different exposure protocols, suggesting a good local tolerability profile. Modifications of the superficial layers were observed on histo-morphological analysis and confirmed by increased release of LDH after 24+16 hrs acute exposure (+65% and +76% for Protectorial and Edenight, respectively) and TEER values after 24+16 hrs and 72 hrs exposure protocols. These results were dependent on the ointments’ accumulation on the corneal epithelium due to their physical form (semi-solid) and lipophilic properties.Conclusion: Sodium hydroxymethylglycinate, alone or as part of eye ointments, was found to be non-toxic after acute or repeated exposure in the reconstructed HCE model.Keywords: BAK, biocompatibility, delayed toxicity, HCE, microglycine
format	article
author	Ceriotti L Balzaretti S Barone S Meloni M
author_facet	Ceriotti L Balzaretti S Barone S Meloni M
author_sort	Ceriotti L
title	Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
title_short	Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
title_full	Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
title_fullStr	Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
title_full_unstemmed	Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium
title_sort	eye irritation potential of microglycine and microglycine-containing ointments: an in vitro study on reconstructed human corneal epithelium
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/8a11e48ce334459db7674892dcbf9599
work_keys_str_mv	AT ceriottil eyeirritationpotentialofmicroglycineandmicroglycinecontainingointmentsaninvitrostudyonreconstructedhumancornealepithelium AT balzarettis eyeirritationpotentialofmicroglycineandmicroglycinecontainingointmentsaninvitrostudyonreconstructedhumancornealepithelium AT barones eyeirritationpotentialofmicroglycineandmicroglycinecontainingointmentsaninvitrostudyonreconstructedhumancornealepithelium AT melonim eyeirritationpotentialofmicroglycineandmicroglycinecontainingointmentsaninvitrostudyonreconstructedhumancornealepithelium
_version_	1718399884112953344

Eye Irritation Potential of Microglycine and Microglycine-Containing Ointments: An in vitro Study on Reconstructed Human Corneal Epithelium

Ejemplares similares